TD Asset Management Inc Has $17.92 Million Position in Axon Enterprise, Inc (NASDAQ:AXON)

Key Points

• TD Asset Management Inc has increased its holdings in Axon Enterprise by 2.2%, now owning 34,078 shares worth approximately $17.9 million.
• Insiders at Axon Enterprise sold a total of 34,642 shares, valued at over $25 million, reflecting a decrease in their ownership.
• Shares of Axon Enterprise opened at $728.74, with significant growth reported, including a 31.3% increase in quarterly revenue compared to the previous year.

TD Asset Management Inc lifted its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 2.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,078 shares of the biotechnology company's stock after acquiring an additional 726 shares during the quarter. TD Asset Management Inc's holdings in Axon Enterprise were worth $17,923,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Fourth Dimension Wealth LLC acquired a new position in Axon Enterprise in the fourth quarter valued at approximately $30,000. Bartlett & CO. Wealth Management LLC lifted its holdings in shares of Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 33 shares during the last quarter. Catalyst Capital Advisors LLC acquired a new position in Axon Enterprise during the 1st quarter valued at approximately $32,000. Alpine Bank Wealth Management bought a new position in Axon Enterprise during the 1st quarter worth $40,000. Finally, Elequin Capital LP acquired a new stake in Axon Enterprise in the fourth quarter worth $46,000. 79.08% of the stock is currently owned by institutional investors.

Insider Activity

In other Axon Enterprise news, CFO Brittany Bagley sold 3,400 shares of the business's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $700.00, for a total value of $2,380,000.00. Following the completion of the sale, the chief financial officer directly owned 131,833 shares of the company's stock, valued at $92,283,100. The trade was a 2.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Michael Garnreiter sold 5,913 shares of the firm's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the transaction, the director owned 17,740 shares in the company, valued at $13,482,400. This represents a 25.00% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,642 shares of company stock valued at $25,090,528. 4.40% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Barclays raised their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Morgan Stanley set a $885.00 price target on shares of Axon Enterprise and gave the stock an "overweight" rating in a research report on Friday, July 11th. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a research report on Thursday, July 17th. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $772.08.

Axon Enterprise Stock Down 3.3%

Shares of NASDAQ:AXON traded down $24.81 during trading on Friday, reaching $730.68. 75,464 shares of the company traded hands, compared to its average volume of 693,343. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. Axon Enterprise, Inc has a 1-year low of $279.02 and a 1-year high of $830.21. The firm has a fifty day simple moving average of $764.32 and a 200 day simple moving average of $655.08. The firm has a market cap of $56.88 billion, a P/E ratio of 176.49, a price-to-earnings-growth ratio of 83.44 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The business's quarterly revenue was up 31.3% on a year-over-year basis. During the same period last year, the business earned $1.15 EPS. Analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.